investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Identification of new microRNA biomarkers and candidate target genes in primitive CML cells using global comparative RNA analyses
Hanyang Lin
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hanyang Lin
BC Cancer Agency
Vancouver, Canada
Related projects
Aaron David Schimmer
Inhibiting oncogenic kinases to target metabolism in AML
Leukaemia
Peter Stirling
Mechanisms of genome instability induced by RNA splicing defects
Leukaemia
Daniel Fowler
Combination Gene Therapy and Th1/Th2 Therapy
Leukaemia
Hematology and hematologic malignancies
Brent Williams
Immunotherapy of leukemic stem cells
Leukaemia
Paul Miller
Regulation of human hematopoietic cells with rapid in vivo repopulating activity
Leukaemia
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Leukaemia
Pathology
Hematology and hematologic malignancies
David H Haussler
Center for Big Data in Translational Genomics
Leukaemia
James Kochenderfer
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
Leukaemia
Hematology and hematologic malignancies
Aaron David Schimmer
Targeting mitochondrial translation as a novel therapeutic strategy for AML
Leukaemia